Communications: News

From MDH: Updates to the Communicable Disease Reporting Rules

Friday, January 6, 2017   (0 Comments)
Posted by: Tara Owens
Share |

On January 8, 2017, changes to the Minnesota’s Communicable Disease Reporting Rule will take effect.

The changes address new and emerging infectious diseases, changes in clinical practice, and help ensure a strong public health system. Changes include:

  • Require reporting of the following communicable diseases.
    • Free-living amebic infection (e.g., Naegleria Fowleri, Balamuthia spp.)
    • Middle East Respiratory Syndrome (MERS)
    • Viral hemorrhagic fever (e.g., Ebola virus disease and Lassa fever)
    • Powassan virus disease and Jamestown Canyon virus disease
    • Carbapenem-resistant Enterobacteriaceae (CRE)
    • Chikungunya virus disease
    • Zika virus disease
  • Removed the requirement to submit clinical materials for HIV and acquired immunodeficiency syndrome (AIDS).
  • Expanded reporting of Lyme disease to include other Borrelia species.
  • Added the requirement that laboratories report hepatitis C virus (HCV) and hepatitis B virus (HBV) viral-detection laboratory test results to the Minnesota Department of Health.
  • Added the requirement to submit clinical materials for mumps disease.
  • Added the requirement to report Streptococcus pneumoniae when a laboratory confirms it through a urine-antigen test.
  • Replaced the term “physician” with the word “health care practitioner.”

For more detail on all the changes to the law, see the attached fact sheet. The Infectious Disease Reporting website is also be revised to reflect the changes on January 9, after the changes take effect.

Membership Software Powered by YourMembership  ::  Legal